Everything I say is in my opinion, do your own DD and make your decision wisely! Don't spend more then you can afford to lose, OTC's are Cruel at Best
Followers | 1070 |
Posts | 136,187 |
Boards Moderated | 0 |
Alias Born | 08/25/2010 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$ADIA .0149 Ony 21m Float, Inside hold 75m. Solid Acquisition
$ADIA .0149 Ony 21m Float, Inside hold 75m. Solid Acquisition
$Adia .0149 About to explode ADIA Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio with Organic Protein and Mushroom Coffee
https://www.biolete.com/
$ADIA .0141 HUGE ACQUISITION NEWS»» Adia Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio with Organic Protein and Mushroom Coffee
Newsfile Corp.
Newsfile Corp
Winter Park, Florida--(Newsfile Corp. - July 23, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA), an innovative provider of nutritional supplements, is pleased to announce the acquisition of Biolete LLC, a pioneering company in the development of protein coffee with mushrooms. This strategic move marks a significant milestone for ADIA Nutrition as it continues to expand its portfolio and provide original solutions to meet the evolving needs of its customers.
Biolete
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/217169_bioleteimage1.jpg
Protein coffees and mushroom extracts have recently gained considerable attention for their potential health benefits, including increased energy, improved focus, and enhanced immune support. Biolete prides itself for its US manufactured coffee with organic ingredients of collagen protein and mushrooms which gives the energy-boosting benefits of coffee without the negative side effects. By acquiring 100% of Biolete, including its trademarks, inventory, customer base, and website, ADIA Nutrition is poised to strengthen its position in the rapidly growing functional beverage market.
"We are thrilled to welcome Biolete to the ADIA family," said Larry Powalisz, CEO of ADIA Nutrition Inc. "Biolete's innovative approach to combining the benefits of protein and mushrooms in a delicious coffee beverage aligns perfectly with our mission to revolutionize the supplement industry and empower individuals to prioritize their health and well-being. We are excited to leverage our combined resources and expertise to bring Biolete's exceptional product to a wider audience."
Biolete accepted ADIA's equity offer of preferred shares that are regulated under Rule 144 (which does not affect the current outstanding shares of the company). This acquisition is a testament to ADIA's commitment to expanding its product offerings and delivering value to their shareholders.
Kevin Masson, founder of Biolete, expressed his enthusiasm for the acquisition, stating, "I am excited to have sold Biolete to ADIA Nutrition as an equity investment. I believe that ADIA Nutrition is the perfect partner to help take Biolete to the next level and continue to provide our customers with the highest quality products."
The acquisition of Biolete is expected to immediately attribute to ADIA Nutrition's earnings and will provide new opportunities for growth and expansion. The company plans to integrate Biolete's operations seamlessly and add additional distribution channels to accelerate the adoption of its protein and mushroom coffee.
For media inquiries or further information, please contact Larry Powalisz at ceo @101Dahlias-0850.
Biolete.com
adianutrition.com or X (Twitter) "adia_nutrition"
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
$Adia .0149 About to explode ADIA Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio with Organic Protein and Mushroom Coffee
https://www.biolete.com/
$ADIA .0141 HUGE ACQUISITION NEWS»» Adia Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio with Organic Protein and Mushroom Coffee
Newsfile Corp.
Newsfile Corp
Winter Park, Florida--(Newsfile Corp. - July 23, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA), an innovative provider of nutritional supplements, is pleased to announce the acquisition of Biolete LLC, a pioneering company in the development of protein coffee with mushrooms. This strategic move marks a significant milestone for ADIA Nutrition as it continues to expand its portfolio and provide original solutions to meet the evolving needs of its customers.
Biolete
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/217169_bioleteimage1.jpg
Protein coffees and mushroom extracts have recently gained considerable attention for their potential health benefits, including increased energy, improved focus, and enhanced immune support. Biolete prides itself for its US manufactured coffee with organic ingredients of collagen protein and mushrooms which gives the energy-boosting benefits of coffee without the negative side effects. By acquiring 100% of Biolete, including its trademarks, inventory, customer base, and website, ADIA Nutrition is poised to strengthen its position in the rapidly growing functional beverage market.
"We are thrilled to welcome Biolete to the ADIA family," said Larry Powalisz, CEO of ADIA Nutrition Inc. "Biolete's innovative approach to combining the benefits of protein and mushrooms in a delicious coffee beverage aligns perfectly with our mission to revolutionize the supplement industry and empower individuals to prioritize their health and well-being. We are excited to leverage our combined resources and expertise to bring Biolete's exceptional product to a wider audience."
Biolete accepted ADIA's equity offer of preferred shares that are regulated under Rule 144 (which does not affect the current outstanding shares of the company). This acquisition is a testament to ADIA's commitment to expanding its product offerings and delivering value to their shareholders.
Kevin Masson, founder of Biolete, expressed his enthusiasm for the acquisition, stating, "I am excited to have sold Biolete to ADIA Nutrition as an equity investment. I believe that ADIA Nutrition is the perfect partner to help take Biolete to the next level and continue to provide our customers with the highest quality products."
The acquisition of Biolete is expected to immediately attribute to ADIA Nutrition's earnings and will provide new opportunities for growth and expansion. The company plans to integrate Biolete's operations seamlessly and add additional distribution channels to accelerate the adoption of its protein and mushroom coffee.
For media inquiries or further information, please contact Larry Powalisz at ceo @101Dahlias-0850.
Biolete.com
adianutrition.com or X (Twitter) "adia_nutrition"
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
$ADIA .0145 falling HUGE ACQUISITION NEWS»» Adia Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio with Organic Protein and Mushroom Coffee
Newsfile Corp.
Newsfile Corp
Winter Park, Florida--(Newsfile Corp. - July 23, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA), an innovative provider of nutritional supplements, is pleased to announce the acquisition of Biolete LLC, a pioneering company in the development of protein coffee with mushrooms. This strategic move marks a significant milestone for ADIA Nutrition as it continues to expand its portfolio and provide original solutions to meet the evolving needs of its customers.
Biolete
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/217169_bioleteimage1.jpg
Protein coffees and mushroom extracts have recently gained considerable attention for their potential health benefits, including increased energy, improved focus, and enhanced immune support. Biolete prides itself for its US manufactured coffee with organic ingredients of collagen protein and mushrooms which gives the energy-boosting benefits of coffee without the negative side effects. By acquiring 100% of Biolete, including its trademarks, inventory, customer base, and website, ADIA Nutrition is poised to strengthen its position in the rapidly growing functional beverage market.
"We are thrilled to welcome Biolete to the ADIA family," said Larry Powalisz, CEO of ADIA Nutrition Inc. "Biolete's innovative approach to combining the benefits of protein and mushrooms in a delicious coffee beverage aligns perfectly with our mission to revolutionize the supplement industry and empower individuals to prioritize their health and well-being. We are excited to leverage our combined resources and expertise to bring Biolete's exceptional product to a wider audience."
Biolete accepted ADIA's equity offer of preferred shares that are regulated under Rule 144 (which does not affect the current outstanding shares of the company). This acquisition is a testament to ADIA's commitment to expanding its product offerings and delivering value to their shareholders.
Kevin Masson, founder of Biolete, expressed his enthusiasm for the acquisition, stating, "I am excited to have sold Biolete to ADIA Nutrition as an equity investment. I believe that ADIA Nutrition is the perfect partner to help take Biolete to the next level and continue to provide our customers with the highest quality products."
The acquisition of Biolete is expected to immediately attribute to ADIA Nutrition's earnings and will provide new opportunities for growth and expansion. The company plans to integrate Biolete's operations seamlessly and add additional distribution channels to accelerate the adoption of its protein and mushroom coffee.
For media inquiries or further information, please contact Larry Powalisz at ceo @101Dahlias-0850.
Biolete.com
adianutrition.com or X (Twitter) "adia_nutrition"
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
$ADIA .0145 falling HUGE ACQUISITION NEWS»» Adia Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio with Organic Protein and Mushroom Coffee
Newsfile Corp.
Newsfile Corp
Winter Park, Florida--(Newsfile Corp. - July 23, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA), an innovative provider of nutritional supplements, is pleased to announce the acquisition of Biolete LLC, a pioneering company in the development of protein coffee with mushrooms. This strategic move marks a significant milestone for ADIA Nutrition as it continues to expand its portfolio and provide original solutions to meet the evolving needs of its customers.
Biolete
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/217169_bioleteimage1.jpg
Protein coffees and mushroom extracts have recently gained considerable attention for their potential health benefits, including increased energy, improved focus, and enhanced immune support. Biolete prides itself for its US manufactured coffee with organic ingredients of collagen protein and mushrooms which gives the energy-boosting benefits of coffee without the negative side effects. By acquiring 100% of Biolete, including its trademarks, inventory, customer base, and website, ADIA Nutrition is poised to strengthen its position in the rapidly growing functional beverage market.
"We are thrilled to welcome Biolete to the ADIA family," said Larry Powalisz, CEO of ADIA Nutrition Inc. "Biolete's innovative approach to combining the benefits of protein and mushrooms in a delicious coffee beverage aligns perfectly with our mission to revolutionize the supplement industry and empower individuals to prioritize their health and well-being. We are excited to leverage our combined resources and expertise to bring Biolete's exceptional product to a wider audience."
Biolete accepted ADIA's equity offer of preferred shares that are regulated under Rule 144 (which does not affect the current outstanding shares of the company). This acquisition is a testament to ADIA's commitment to expanding its product offerings and delivering value to their shareholders.
Kevin Masson, founder of Biolete, expressed his enthusiasm for the acquisition, stating, "I am excited to have sold Biolete to ADIA Nutrition as an equity investment. I believe that ADIA Nutrition is the perfect partner to help take Biolete to the next level and continue to provide our customers with the highest quality products."
The acquisition of Biolete is expected to immediately attribute to ADIA Nutrition's earnings and will provide new opportunities for growth and expansion. The company plans to integrate Biolete's operations seamlessly and add additional distribution channels to accelerate the adoption of its protein and mushroom coffee.
For media inquiries or further information, please contact Larry Powalisz at ceo @101Dahlias-0850.
Biolete.com
adianutrition.com or X (Twitter) "adia_nutrition"
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
$ADIA .0141 HUGE ACQUISITION NEWS»» Adia Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio with Organic Protein and Mushroom Coffee
Newsfile Corp.
Newsfile Corp
Winter Park, Florida--(Newsfile Corp. - July 23, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA), an innovative provider of nutritional supplements, is pleased to announce the acquisition of Biolete LLC, a pioneering company in the development of protein coffee with mushrooms. This strategic move marks a significant milestone for ADIA Nutrition as it continues to expand its portfolio and provide original solutions to meet the evolving needs of its customers.
Biolete
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/217169_bioleteimage1.jpg
Protein coffees and mushroom extracts have recently gained considerable attention for their potential health benefits, including increased energy, improved focus, and enhanced immune support. Biolete prides itself for its US manufactured coffee with organic ingredients of collagen protein and mushrooms which gives the energy-boosting benefits of coffee without the negative side effects. By acquiring 100% of Biolete, including its trademarks, inventory, customer base, and website, ADIA Nutrition is poised to strengthen its position in the rapidly growing functional beverage market.
"We are thrilled to welcome Biolete to the ADIA family," said Larry Powalisz, CEO of ADIA Nutrition Inc. "Biolete's innovative approach to combining the benefits of protein and mushrooms in a delicious coffee beverage aligns perfectly with our mission to revolutionize the supplement industry and empower individuals to prioritize their health and well-being. We are excited to leverage our combined resources and expertise to bring Biolete's exceptional product to a wider audience."
Biolete accepted ADIA's equity offer of preferred shares that are regulated under Rule 144 (which does not affect the current outstanding shares of the company). This acquisition is a testament to ADIA's commitment to expanding its product offerings and delivering value to their shareholders.
Kevin Masson, founder of Biolete, expressed his enthusiasm for the acquisition, stating, "I am excited to have sold Biolete to ADIA Nutrition as an equity investment. I believe that ADIA Nutrition is the perfect partner to help take Biolete to the next level and continue to provide our customers with the highest quality products."
The acquisition of Biolete is expected to immediately attribute to ADIA Nutrition's earnings and will provide new opportunities for growth and expansion. The company plans to integrate Biolete's operations seamlessly and add additional distribution channels to accelerate the adoption of its protein and mushroom coffee.
For media inquiries or further information, please contact Larry Powalisz at ceo @101Dahlias-0850.
Biolete.com
adianutrition.com or X (Twitter) "adia_nutrition"
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
$ADIA .0141 HUGE ACQUISITION NEWS»» Adia Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio with Organic Protein and Mushroom Coffee
Newsfile Corp.
Newsfile Corp
Winter Park, Florida--(Newsfile Corp. - July 23, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA), an innovative provider of nutritional supplements, is pleased to announce the acquisition of Biolete LLC, a pioneering company in the development of protein coffee with mushrooms. This strategic move marks a significant milestone for ADIA Nutrition as it continues to expand its portfolio and provide original solutions to meet the evolving needs of its customers.
Biolete
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/217169_bioleteimage1.jpg
Protein coffees and mushroom extracts have recently gained considerable attention for their potential health benefits, including increased energy, improved focus, and enhanced immune support. Biolete prides itself for its US manufactured coffee with organic ingredients of collagen protein and mushrooms which gives the energy-boosting benefits of coffee without the negative side effects. By acquiring 100% of Biolete, including its trademarks, inventory, customer base, and website, ADIA Nutrition is poised to strengthen its position in the rapidly growing functional beverage market.
"We are thrilled to welcome Biolete to the ADIA family," said Larry Powalisz, CEO of ADIA Nutrition Inc. "Biolete's innovative approach to combining the benefits of protein and mushrooms in a delicious coffee beverage aligns perfectly with our mission to revolutionize the supplement industry and empower individuals to prioritize their health and well-being. We are excited to leverage our combined resources and expertise to bring Biolete's exceptional product to a wider audience."
Biolete accepted ADIA's equity offer of preferred shares that are regulated under Rule 144 (which does not affect the current outstanding shares of the company). This acquisition is a testament to ADIA's commitment to expanding its product offerings and delivering value to their shareholders.
Kevin Masson, founder of Biolete, expressed his enthusiasm for the acquisition, stating, "I am excited to have sold Biolete to ADIA Nutrition as an equity investment. I believe that ADIA Nutrition is the perfect partner to help take Biolete to the next level and continue to provide our customers with the highest quality products."
The acquisition of Biolete is expected to immediately attribute to ADIA Nutrition's earnings and will provide new opportunities for growth and expansion. The company plans to integrate Biolete's operations seamlessly and add additional distribution channels to accelerate the adoption of its protein and mushroom coffee.
For media inquiries or further information, please contact Larry Powalisz at ceo @101Dahlias-0850.
Biolete.com
adianutrition.com or X (Twitter) "adia_nutrition"
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
$ADIA .0141 Solid Acquisition »» Acquisition Transaction
On July 11, 2024, Adia Nutrition, Inc., a Nevada corporation (the “Company”), and the owners of Biolete, LLC (“Biolete”), a
privately-held, Florida-based company that manufactures and sells Biolete’s Protein Coffee, entered into a membership interest purchase
agreement (the “Biolete Agreement”), pursuant to which the Companywould acquire 100% ownership ofBiolete. The Company isto issue
a total of 1,750,000 shares of its Series C Preferred Stock at the closing of the Biolete Agreement (See “Designation of Series C Preferred
Stock” below). Company management expects the Biolete Agreement to close in near future and sees no impediment to such closing.
More information about Biolete can be found online at www.biolete.com.
Designation of Series C Preferred Stock
On July 3, 2024, the Company filed with the State of Nevada a Certificate of Designation (the “Certificate of Designation”),
which established a Series C Preferred Stock with the following rights, preferences, powers, restrictions and limitations:
Section 1. Designation, Amount and Par Value. The series of Preferred Stock shall be designated as Series C Preferred
Stock (the “Series C Preferred Stock”) and the number of shares so designated shall be Eighty-Nine Million Nine Hundred
Ninety-Nine Thousand Nine-Hundred Ninety Nine (89,999,999). Each share ofthe Series C Preferred Stock shall have a par value
of $0.001.
Section 2. Fractional Shares. The Series C Preferred Stock may be issued in fractional shares.
Section 3. Voting Rights. Each share the Series C Preferred Stock shall have one (1) vote in all matters requiring
shareholder approval.
Section 4. Dividends. The Series C Preferred Stock shall be treated pari passu with the Company’s common stock, except
that the dividend on each share of Series C Preferred Stock shall be equal to the amount of the dividend declared and paid on each
share of the Company’s common stock multiplied by the Conversion Rate, as that term is defined in Section 6(a).
Section 5. Liquidation. Upon any liquidation, dissolution or winding up of the Company, whether voluntary or
involuntary, payments to the holders of Series C Preferred Stock shall be treated pari passu with the Company’s common stock,
except that the payment on each share of Series C Preferred Stock shall be equal to the amount of the payment on each share of
the Company’s common stock multiplied by the Conversion Rate, as that term is defined in Section 6(a).
Section 6. Conversion and Adjustments.
(a) Conversion Rate. Each shares of Series C Preferred Stock shall be convertible into four (4) shares of
the Company’s common stock (the “Conversion Rate”).
The Conversion Rate shall not be subject to adjustment by a combination of the outstanding shares of the
Company’s common stock into a smaller number of shares of common stock.
The ConversionRate shall be subject to adjustment by a subdivision ofthe outstanding shares ofthe Company’s
common stock into a greater number of shares of common stock (the “Common Stock Event”) by multiplying the Conversion
Rate then in effect by a fraction: (1) the numerator of which shall be the number of shares of Company common stock issued and
outstanding immediately prior to such Common Stock Event and (2) the denominator of which shall be the number of shares of
Company common stock issued and outstanding immediately after such Common Stock Event.
(b) Partial Conversion. A holder ofshares of Series C Preferred Stock shall have the right to convert, from
time to time, some or all of such holder’s shares of Series C Preferred Stock.
SUPPLEMENTAL INFORMATION — JUL(c) Adjustment for Merger and Reorganization, etc. If there shall occur any reorganization,
recapitalization, reclassification, consolidation or merger (a “Reorganization Event”) involving the Company in which the
Company’s common stock (but not the Series C Preferred Stock) is converted into or exchanged for securities, cash or other
property, then each share of Series C Preferred Stock shall be deemed to have been converted into shares of the Company’s
common stock at the Conversion Rate.
Section 7. Protection Provisions. So long as any shares of Series C Preferred Stock are outstanding, the Company shall
not, without first obtaining the written consent of the holders of a majority the Series C Preferred Stock, alter or change the rights,
preferences or privileges of the Series C Preferred Stock.
Section 8. Waiver. Any of the rights, powers or preferences of the holders of the Series C Preferred Stock may be waived
by the affirmative consent or vote of the holders of at least a majority of the shares of Series C Preferred Stock then outstanding.
Section 9. No Other Rights or Privileges. Except as specifically set forth herein, the holder(s) of the shares of Series C
Preferred Stock shall have no other rights, privileges or preferences with respect to the Series C Preferred Stock.
SIGNATURES
Dated: July 12, 2024.
/s/ Larry Powalisz
Chief Executive Officer
Adia Nutrition, Inc.
$ADIA .0141 Solid Acquisition »» Acquisition Transaction
On July 11, 2024, Adia Nutrition, Inc., a Nevada corporation (the “Company”), and the owners of Biolete, LLC (“Biolete”), a
privately-held, Florida-based company that manufactures and sells Biolete’s Protein Coffee, entered into a membership interest purchase
agreement (the “Biolete Agreement”), pursuant to which the Companywould acquire 100% ownership ofBiolete. The Company isto issue
a total of 1,750,000 shares of its Series C Preferred Stock at the closing of the Biolete Agreement (See “Designation of Series C Preferred
Stock” below). Company management expects the Biolete Agreement to close in near future and sees no impediment to such closing.
More information about Biolete can be found online at www.biolete.com.
Designation of Series C Preferred Stock
On July 3, 2024, the Company filed with the State of Nevada a Certificate of Designation (the “Certificate of Designation”),
which established a Series C Preferred Stock with the following rights, preferences, powers, restrictions and limitations:
Section 1. Designation, Amount and Par Value. The series of Preferred Stock shall be designated as Series C Preferred
Stock (the “Series C Preferred Stock”) and the number of shares so designated shall be Eighty-Nine Million Nine Hundred
Ninety-Nine Thousand Nine-Hundred Ninety Nine (89,999,999). Each share ofthe Series C Preferred Stock shall have a par value
of $0.001.
Section 2. Fractional Shares. The Series C Preferred Stock may be issued in fractional shares.
Section 3. Voting Rights. Each share the Series C Preferred Stock shall have one (1) vote in all matters requiring
shareholder approval.
Section 4. Dividends. The Series C Preferred Stock shall be treated pari passu with the Company’s common stock, except
that the dividend on each share of Series C Preferred Stock shall be equal to the amount of the dividend declared and paid on each
share of the Company’s common stock multiplied by the Conversion Rate, as that term is defined in Section 6(a).
Section 5. Liquidation. Upon any liquidation, dissolution or winding up of the Company, whether voluntary or
involuntary, payments to the holders of Series C Preferred Stock shall be treated pari passu with the Company’s common stock,
except that the payment on each share of Series C Preferred Stock shall be equal to the amount of the payment on each share of
the Company’s common stock multiplied by the Conversion Rate, as that term is defined in Section 6(a).
Section 6. Conversion and Adjustments.
(a) Conversion Rate. Each shares of Series C Preferred Stock shall be convertible into four (4) shares of
the Company’s common stock (the “Conversion Rate”).
The Conversion Rate shall not be subject to adjustment by a combination of the outstanding shares of the
Company’s common stock into a smaller number of shares of common stock.
The ConversionRate shall be subject to adjustment by a subdivision ofthe outstanding shares ofthe Company’s
common stock into a greater number of shares of common stock (the “Common Stock Event”) by multiplying the Conversion
Rate then in effect by a fraction: (1) the numerator of which shall be the number of shares of Company common stock issued and
outstanding immediately prior to such Common Stock Event and (2) the denominator of which shall be the number of shares of
Company common stock issued and outstanding immediately after such Common Stock Event.
(b) Partial Conversion. A holder ofshares of Series C Preferred Stock shall have the right to convert, from
time to time, some or all of such holder’s shares of Series C Preferred Stock.
SUPPLEMENTAL INFORMATION — JUL(c) Adjustment for Merger and Reorganization, etc. If there shall occur any reorganization,
recapitalization, reclassification, consolidation or merger (a “Reorganization Event”) involving the Company in which the
Company’s common stock (but not the Series C Preferred Stock) is converted into or exchanged for securities, cash or other
property, then each share of Series C Preferred Stock shall be deemed to have been converted into shares of the Company’s
common stock at the Conversion Rate.
Section 7. Protection Provisions. So long as any shares of Series C Preferred Stock are outstanding, the Company shall
not, without first obtaining the written consent of the holders of a majority the Series C Preferred Stock, alter or change the rights,
preferences or privileges of the Series C Preferred Stock.
Section 8. Waiver. Any of the rights, powers or preferences of the holders of the Series C Preferred Stock may be waived
by the affirmative consent or vote of the holders of at least a majority of the shares of Series C Preferred Stock then outstanding.
Section 9. No Other Rights or Privileges. Except as specifically set forth herein, the holder(s) of the shares of Series C
Preferred Stock shall have no other rights, privileges or preferences with respect to the Series C Preferred Stock.
SIGNATURES
Dated: July 12, 2024.
/s/ Larry Powalisz
Chief Executive Officer
Adia Nutrition, Inc.
$ADIA .0141 First News in Years »» ADIA Nutrition Inc. Announces Restructuring, Unveiling Two Dynamic Divisions
https://www.otcmarkets.com/otcapi/company/financial-report/394470/content
$ADIA .0141 First News in Years »» ADIA Nutrition Inc. Announces Restructuring, Unveiling Two Dynamic Divisions
https://www.otcmarkets.com/otcapi/company/financial-report/394470/content
Very wrong »» NOTE 5 – NOTES PAYABLE AND RELATED PARTIES.
There were no convertible notes payable during the period.
NOTE 6 –CONVERTIBLE NOTES PAYABLE
There were no convertible notes payable during this period.
https://www.otcmarkets.com/otcapi/company/financial-report/394470/content
Someone's claiming it's a shell is a complete moron, and needs to learn to do a lil due Diligence being making such a preposterous statement.
$ADIA .0145 up Looks like it will hit .05-.10
$ADIA .0145 up Looks like it will hit .05-.10
$ADIA Looks like it will hit .05-.10
$ADIA Looks like it will hit .05-.10
$ADIA .0125 Breaking out, 1st news in years, Huge Acquisition and Reinstated
$ADIA .0125 Breaking out, 1st news in years, Huge Acquisition and Reinstated
$ADIA Big News Out »» Nutrition Inc. Announces Restructuring, Unveiling Two Dynamic Divisions
Huge News after the Acquisition Filing!!
21m Shares
https://www.otcmarkets.com/stock/ADIA/news/story?e&id=2921298
$ADIA .0125 Big News Out »» Nutrition Inc. Announces Restructuring, Unveiling Two Dynamic Divisions
Huge News after the Acquisition Filing!!
21m Shares
https://www.otcmarkets.com/stock/ADIA/news/story?e&id=2921298
$ADIA .0125 Big News Out »» Nutrition Inc. Announces Restructuring, Unveiling Two Dynamic Divisions
Huge News after the Acquisition Filing!!
21m Shares
https://www.otcmarkets.com/stock/ADIA/news/story?e&id=2921298
$ADIA .0118 40k left, Clean Shell Reinstated/Acquisition of Biolete Lcc. 21m Shares!!
https://www.biolete.com/
https://www.otcmarkets.com/otcapi/company/financial-report/407434/content
$ADIA .0118 40k left, Clean Shell Reinstated/Acquisition of Biolete Lcc. 21m Shares!!
https://www.biolete.com/
https://www.otcmarkets.com/otcapi/company/financial-report/407434/content
$ADIA .0119 Huge Clean Shell Reinstated//Merged with Biolete, real revenue and amazing product line.
Micro Floater will hit $0.10+
biolete.com
otcmarkets.com/otcapi/company…
$ADIA .0119 Huge Clean Shell Reinstated//Merged with Biolete, real revenue and amazing product line.
Micro Floater will hit $0.10+
biolete.com
otcmarkets.com/otcapi/company…
The Acquisition BIOLETE is already on the website for $ADIA pretty much sums everything up. The Acquisition is complete »» https://adianutrition.com/
$ADIA .01 Huge Merger, VOLUME Coming in
$ADIA .01 Huge Merger, VOLUME Coming in
$ADIA .01 Huge Merger, hit $0.15+ no shares
$ADIA .01 Huge Merger, hit $0.15+ no shares
$ADIA. 01 FILING OUT CLEAN SHELL MERGER
All Over #Facebook, #YouTube, and #Instagram with amazing products and Revenues
Clean Shell #Merger Folks
Explosive when noticed. Huge News 21m Floater
https://www.otcmarkets.com/otcapi/company/financial-report/407434/content
$ADIA. 01 FILING OUT CLEAN SHELL MERGER
All Over #Facebook, #YouTube, and #Instagram with amazing products and Revenues
Clean Shell #Merger Folks
Explosive when noticed. Huge News 21m Floater
https://www.otcmarkets.com/otcapi/company/financial-report/407434/content
$ADIA .0115 Going on Huge News 21m Floater »» https://www.otcmarkets.com/otcapi/company/financial-report/407434/content
$ADIA .0115 Going on Huge News 21m Floater »» https://www.otcmarkets.com/otcapi/company/financial-report/407434/content
$ADIA .01 Huge Merger 21m Floater »» https://www.otcmarkets.com/otcapi/company/financial-report/407434/content
$ADIA .01 Huge Merger 21m Floater »» https://www.otcmarkets.com/otcapi/company/financial-report/407434/content
$DPUI .0017 STRONG BUY, Quit buying Dilutive Crap
$DPUI .0017 STRONG BUY, Quit buying Dilutive Crap